Literature DB >> 8163024

Replacement of proteasome subunits X and Y by LMP7 and LMP2 induced by interferon-gamma for acquirement of the functional diversity responsible for antigen processing.

K Akiyama1, S Kagawa, T Tamura, N Shimbara, M Takashina, P Kristensen, K B Hendil, K Tanaka, A Ichihara.   

Abstract

Proteasomes catalyze the non-lysosomal, ATP-dependent selective breakdown of ubiquitinated proteins and are thought to be responsible for MHC class I-restricted antigen presentation. Recently, we reported that gamma interferon (IFN-gamma) induced not only marked synthesis of the MHC-encoded proteasome subunits LMP2 and LMP7, but also almost complete loss of two unidentified proteasome subunits tentatively designated as X and Y in various human cells. Here, we show that subunit X is a new proteasomal subunit highly homologous to LMP7, and that subunit Y is identical to the LMP2-related proteasomal subunit delta. Thus, IFN-gamma appears to induce subunit replacements of X and Y by LMP7 and LMP2, respectively, producing 'immuno-proteasomes' with the functional diversity responsible for processing of endogenous antigens.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8163024     DOI: 10.1016/0014-5793(94)80612-8

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  28 in total

1.  Innate and acquired immunity intersect in a global view of the acute-phase response.

Authors:  Joo-Yeon Yoo; Stephen Desiderio
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-22       Impact factor: 11.205

2.  Effects of aging and dietary restriction on ubiquitination, sumoylation, and the proteasome in the spleen.

Authors:  Le Zhang; Feng Li; Edgardo Dimayuga; Jeffrey Craddock; Jeffrey N Keller
Journal:  FEBS Lett       Date:  2007-11-06       Impact factor: 4.124

3.  Epidermal growth factor receptor vIII expression in U87 glioblastoma cells alters their proteasome composition, function, and response to irradiation.

Authors:  Kwanghee Kim; James M Brush; Philip A Watson; Nicholas A Cacalano; Keisuke S Iwamoto; William H McBride
Journal:  Mol Cancer Res       Date:  2008-03       Impact factor: 5.852

4.  Subunit arrangement in the human 20S proteasome.

Authors:  F Kopp; K B Hendil; B Dahlmann; P Kristensen; A Sobek; W Uerkvitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

5.  Subpopulations of proteasomes in rat liver nuclei, microsomes and cytosol.

Authors:  A Palmer; A J Rivett; S Thomson; K B Hendil; G W Butcher; G Fuertes; E Knecht
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

6.  An antigenic peptide produced by reverse splicing and double asparagine deamidation.

Authors:  Alexandre Dalet; Paul F Robbins; Vincent Stroobant; Nathalie Vigneron; Yong F Li; Mona El-Gamil; Ken-ichi Hanada; James C Yang; Steven A Rosenberg; Benoît J Van den Eynde
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-13       Impact factor: 11.205

7.  Role of immunoproteasome catalytic subunits in the immune response to hepatitis B virus.

Authors:  Michael D Robek; Mayra L Garcia; Bryan S Boyd; Francis V Chisari
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103

8.  A prognostic signature of G(2) checkpoint function in melanoma cell lines.

Authors:  Bernard Omolo; Craig Carson; Haitao Chu; Yingchun Zhou; Dennis A Simpson; Jill E Hesse; Richard S Paules; Kristine C Nyhan; Joseph G Ibrahim; William K Kaufmann
Journal:  Cell Cycle       Date:  2013-03-01       Impact factor: 4.534

9.  Human immunodeficiency virus type 1 Gag p24 alters the composition of immunoproteasomes and affects antigen presentation.

Authors:  Nicholas J Steers; Kristina K Peachman; Sasha R McClain; Carl R Alving; Mangala Rao
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

Review 10.  The Immunoproteasome in oxidative stress, aging, and disease.

Authors:  Helen K Johnston-Carey; Laura C D Pomatto; Kelvin J A Davies
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-04-20       Impact factor: 8.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.